| Old Articles: <Older 48421-48430 Newer> |
|---|
 |
The Motley Fool
May 2, 2011
Anupama Pattanaik |
J&J Attempts to Create Major "Synthes"-is Johnson & Johnson will acquire the medical device maker for $21.3 billion.   |
The Motley Fool
May 2, 2011
Suman Chatterjee |
How Smart Was ValueClick's Acquisition? ValueClick bought Greystripe for $70 million. Was it worth it? |
The Motley Fool
May 2, 2011
Arunava De |
Can Research In Motion Withstand the Apple Onslaught? The wireless innovator could still recover from the PlayBook's muted launch. |
The Motley Fool
May 2, 2011
Cindy Johnson |
Pacific Biosciences of California Shares Plunged: What You Need to Know Pacific Biosciences of California dropped 12% in intraday trading today after a news article on hot stock Illumina suggested industry competition is intensifying. |
The Motley Fool
May 2, 2011
Brian Stoffel |
Costco's Living On the Edge Here are two metrics to focus on for growth in this sector. |
The Motley Fool
May 2, 2011
Rich Smith |
Boeing Booted Out of India And Lockheed, too. |
The Motley Fool
May 2, 2011
Suman Chatterjee |
Why the Nuclear Power Industry Looks Shaky If your portfolio contains any nuclear related stock, you should rethink. |
The Motley Fool
May 2, 2011
Arunava De |
Sony PlayStation 3 Is Down, but Is It Out? As competition against PS3 increases, how equipped is the company to fight Xbox and Wii. |
The Motley Fool
May 2, 2011
Isac Simon |
Energy XXI Showing Very Strong Results Acquisitions over the years and increased production have reflected positively on Energy XXI's quarterly numbers. |
The Motley Fool
May 2, 2011
Tim Beyers |
Spectrum Pharmaceuticals Shares Popped: What You Need to Know Shares of Spectrum Pharmaceuticals rose as much as 14% in intraday trading after the Food and Drug Administration approved Fusilev as a colon cancer treatment. |
| <Older 48421-48430 Newer> Return to current articles. |
